Business Description
Neurizon Therapeutics Limited is an Australian biotechnology company focused on developing treatments for diseases that damage the nervous system. Founded in 2000 and headquartered in Melbourne, the company was previously called PharmAust Limited before rebranding in October 2024. Its most advanced drug, NUZ-001, is currently in Phase II clinical trials as a potential treatment for ALS and other neurological conditions.
